Clinical Trials · NCT06803888
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- Ali Aminian
- Enrollment
- 140
- Start date
- Jan 2025
- Locations
- 1 site, United States
- Primary endpoint
- Mean percentage total body weight loss at Week 52